candesartan has been researched along with Cicatrix, Hypertrophic in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Cicatrix, Hypertrophic: An elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hypertrophic scars were photographed and analyzed with the program ImageJ quantitatively to determine the degree of collagen fibers." | 1.48 | Comparison of Enalapril, Candesartan and Intralesional Triamcinolone in Reducing Hypertrophic Scar Development: An Experimental Study. ( Basbugan, Y; Demir, CY; Ersoz, ME; Erten, R; Kocak, OF; Sultanoglu, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demir, CY | 1 |
| Ersoz, ME | 1 |
| Erten, R | 1 |
| Kocak, OF | 1 |
| Sultanoglu, Y | 1 |
| Basbugan, Y | 1 |
1 other study available for candesartan and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
Comparison of Enalapril, Candesartan and Intralesional Triamcinolone in Reducing Hypertrophic Scar Development: An Experimental Study.
Topics: Administration, Oral; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzi | 2018 |